tiprankstipranks
Trending News
More News >
Parnell Pharmaceuticals Holdings (PARNF)
OTHER OTC:PARNF
US Market

Parnell Pharmaceuticals (PARNF) Financial Statements

Compare
16 Followers

Parnell Pharmaceuticals Financial Overview

Parnell Pharmaceuticals's market cap is currently $1.45M. The company's EPS TTM is $; its P/E ratio is ―; Parnell Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18
Income Statement
Total RevenueAU$ 34.17MAU$ 30.00MAU$ 28.99MAU$ 26.55M
Gross ProfitAU$ 19.26MAU$ 17.52MAU$ 17.39MAU$ 15.52M
Operating IncomeAU$ 1.35MAU$ 3.78MAU$ 1.36MAU$ 2.61M
EBITDAAU$ 6.00MAU$ 4.23MAU$ 2.40MAU$ 5.26M
Net IncomeAU$ -1.42MAU$ -15.06MAU$ -7.18MAU$ 129.62K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.48MAU$ 4.03MAU$ 4.51MAU$ 4.40M
Total AssetsAU$ 40.11MAU$ 40.58MAU$ 39.04MAU$ 33.48M
Total DebtAU$ 63.38MAU$ 59.68MAU$ 54.67MAU$ 45.04M
Net DebtAU$ 58.89MAU$ 55.66MAU$ 50.16MAU$ 40.64M
Total LiabilitiesAU$ 74.90MAU$ 72.43MAU$ 65.26MAU$ 52.01M
Stockholders' EquityAU$ -34.79MAU$ -31.85MAU$ -26.23MAU$ -18.53M
Cash Flow
Free Cash Flow---AU$ -4.37M
Operating Cash Flow---AU$ -1.62M
Investing Cash Flow---AU$ -2.76M
Financing Cash Flow---AU$ 6.16M
Currency in AUD

Parnell Pharmaceuticals Earnings and Revenue History

Parnell Pharmaceuticals Debt to Assets

Parnell Pharmaceuticals Cash Flow

Parnell Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis